Pharma Base
Pharma Base, headquartered in Switzerland (CH), is a prominent player in the pharmaceutical industry, specialising in the development and manufacturing of high-quality active pharmaceutical ingredients (APIs) and intermediates. Founded in 2001, the company has established a strong presence in Europe and beyond, focusing on innovative solutions that cater to the evolving needs of healthcare providers. With a commitment to excellence, Pharma Base offers a diverse range of products and services, including custom synthesis and contract manufacturing. Their unique approach combines cutting-edge technology with stringent quality control, ensuring that clients receive reliable and effective solutions. Recognised for their expertise, Pharma Base has achieved significant milestones, positioning itself as a trusted partner in the global pharmaceutical market.
DitchCarbon Score
How does Pharma Base's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Pharma Base's score of 6 is higher than 82% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Pharma Base's reported carbon emissions
Pharma Base, headquartered in Switzerland (CH), currently does not have available carbon emissions data for recent years. As a result, specific figures regarding their emissions in kg CO2e, including Scope 1, 2, or 3 emissions, are not provided. In the absence of concrete emissions data, it is important to note that Pharma Base has not outlined any specific reduction targets or climate commitments. This lack of publicly available information may reflect a broader industry context where many companies are increasingly focusing on sustainability and carbon neutrality. As the pharmaceutical sector continues to evolve, stakeholders are encouraged to monitor Pharma Base's future initiatives and commitments towards reducing their carbon footprint and enhancing their climate strategies.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Pharma Base is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
